FDA Warns Cyberonics on Manufacturing  CHICAGO (Reuters) - U.S. regulators warned Cyberonics Inc.  of manufacturing deficiencies at the Houston plant that makes  its sole product, an implantable device to treat epilepsy, the  company said on Monday.